Health Catalyst Inc
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HEALTH CATALYST, INC. | ||
| Date: 2/26/2025 | By: | /s/ Jason Alger |
|---|---|---|
| Jason Alger | ||
| Chief Financial Officer(Principal Financial and Accounting Officer) | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Daniel Burton, Jason Alger, and Benjamin Landry, with full power of substitution and resubstitution, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file, any and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorney-in-fact and agents or any of them or their and his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Daniel Burton | Chief Executive Officer and Director | 2/26/2025 |
| Daniel Burton | (Principal Executive Officer) | |
| /s/ Jason Alger | Chief Financial Officer | 2/26/2025 |
| Jason Alger | (Principal Financial and Accounting Officer) | |
| /s/ John A. Kane | Director | 2/26/2025 |
| John A. Kane | ||
| /s/ Duncan Gallagher | Director | 2/26/2025 |
| Duncan Gallagher | ||
| /s/ Jill Hoggard Green | Director | 2/26/2025 |
| Jill Hoggard Green | ||
| /s/ Matthew Kolb | Director | 2/26/2025 |
| Matthew Kolb | ||
| /s/ Julie Larson-Green | Director | 2/26/2025 |
| Julie Larson-Green | ||
| /s/ Anita V. Pramoda | Director | 2/26/2025 |
| Anita V. Pramoda | ||
| /s/ S. Dawn Smith | Director | 2/26/2025 |
| S. Dawn Smith | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.